Commodore Capital LP
- SEC CIK
- 0001831942
- 最新申報
- 2026/8/14
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/10/14 申報。只含多頭部位。
- 持股檔數
- 31
- 2020 年第 4 季沒有 13F 資料
- 總值
- $2.51 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ACRSAclaris Therapeutics, Inc. | COM | 1,028,084 | $2,591 萬 | 10.3% | – | – | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 481,094 | $1,780 萬 | 7.1% | – | – | 歷史 |
| KURAKura Oncology, Inc. | COM | 521,555 | $1,474 萬 | 5.9% | – | – | 歷史 |
| STSASatsuma Pharmaceuticals, Inc. | COM | 2,431,705 | $1,437 萬 | 5.7% | – | – | 歷史 |
| Five Prime Therapeutics Inc33830X104 | COM | 361,344 | $1,361 萬 | 5.4% | – | – | – |
| CBAYCymaBay Therapeutics, Inc. | COM | 2,983,513 | $1,355 萬 | 5.4% | – | – | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,269,195 | $1,114 萬 | 4.4% | – | – | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 1,729,041 | $1,069 萬 | 4.3% | – | – | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 349,600 | $905.5 萬 | 3.6% | – | – | 歷史 |
| KRONKronos Bio, Inc. | COM | 298,839 | $874.7 萬 | 3.5% | – | – | 歷史 |
| CNSTConstellation Pharmaceuticals Inc | COM | 368,448 | $861.8 萬 | 3.4% | – | – | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 795,868 | $854.8 萬 | 3.4% | – | – | – |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 3,729,694 | $794.4 萬 | 3.2% | – | – | 歷史 |
| GNCAGenocea Biosciences, Inc. | COM NEW | 2,871,624 | $778.2 萬 | 3.1% | – | – | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 369,951 | $762.1 萬 | 3.0% | – | – | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 429,228 | $694.5 萬 | 2.8% | – | – | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 2,048,757 | $690.4 萬 | 2.8% | – | – | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 430,112 | $668.0 萬 | 2.7% | – | – | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 161,565 | $568.9 萬 | 2.3% | – | – | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 214,467 | $551.0 萬 | 2.2% | – | – | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 301,392 | $539.5 萬 | 2.1% | – | – | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 236,500 | $528.8 萬 | 2.1% | – | – | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 176,821 | $513.7 萬 | 2.0% | – | – | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 97,143 | $423.8 萬 | 1.7% | – | – | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 125,000 | $411.1 萬 | 1.6% | – | – | 歷史 |
| IVAInventiva S.A. | ADS | 262,658 | $386.1 萬 | 1.5% | – | – | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 185,781 | $310.4 萬 | 1.2% | – | – | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 141,303 | $290.9 萬 | 1.2% | – | – | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 250,000 | $264.3 萬 | 1.1% | – | – | – |
| MGNXMacrogenics Inc | COM | 46,630 | $148.5 萬 | 0.6% | – | – | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 100,000 | $101.4 萬 | 0.4% | – | – | 歷史 |